N99-02: Melphalan and Buthionine Sulfoximine (BSO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00005835
Recruitment Status : Completed
First Posted : January 27, 2003
Last Update Posted : August 30, 2016
National Cancer Institute (NCI)
Information provided by (Responsible Party):
New Approaches to Neuroblastoma Therapy Consortium